Protein expression was analyzed using immunohistochemistry, mRNA levels were measured using Real-Time PCR, and DNA mutations were found using Sanger Sequencing.<h4>Results</h4>BCL-2 immunohistochemistry indicated decreased expression in HD patients' aganglionic tissues compared to ganglionic tissues (p ≤ 0.001). Here, BCL2 is linked to Huntington disease.